PLAST_CELL partner Cherry Biotech participated in the 2026 MPS World Summit, held from 26 to 29 May 2026 in Washington, DC. The event brought together a global community of researchers, industry representatives, technology developers, and stakeholders working on microphysiological systems, organ-on-chip technologies, and advanced in vitro models.

Cherry Biotech was represented by its CEO, Jérémy Cramer, who used the opportunity to present the company’s work and raise awareness of the PLAST_CELL project among relevant stakeholders. The event also served as a valuable occasion to introduce the newly developed PLAST_CELL brochure, which supported discussions with participants and helped communicate the project’s objectives, technological approach, and expected contribution to the study of cancer cell plasticity.

Through this participation, the team contributed to strengthening the visibility of PLAST_CELL within the microphysiological systems community and supported the project’s dissemination and stakeholder engagement activities.